Author Correction: A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice (Scientific Reports, (2017), 7, 1, (42277), 10.1038/srep42277);A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Sheu, Joen Rong ^a   Chen, Zhih Cherng ^a,b,c   Jayakumar, Thanasekaran ^a   Chou, Duen Suey ^a   Yen, Ting Lin ^a   Lee, Hsing Ni ^a   Pan, Szu Han ^a   Hsia, Chih Hsuan ^a   Yang, Chih Hao ^a   Hsieh, Cheng Ying ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Chia Nan University of Pharmacy and Science   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; COLLAGEN; FREE RADICAL; IMMUNOLOGIC FACTOR; LIPOPOLYSACCHARIDE; NEUROPROTECTIVE AGENT; PLATONIN; STRESS ACTIVATED PROTEIN KINASE; THIAZOLE DERIVATIVE;

ANIMAL; ANIMAL BEHAVIOR; BIOLOGICAL MODEL; BRAIN ISCHEMIA; C57BL MOUSE; CELL DEATH; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CHEMISTRY; COMPLICATION; DISEASE MODEL; DRUG EFFECT; HUMAN; MACROPHAGE; MALE; METABOLISM; MOUSE; NERVE CELL; NEUROPROTECTION; PATHOLOGY; PHOSPHORYLATION; RAW 264.7 CELL LINE; THROMBOCYTE AGGREGATION; TIME FACTOR;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CELL DEATH; COLLAGEN; DISEASE MODELS, ANIMAL; FREE RADICALS; HUMANS; IMMUNOLOGIC FACTORS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NEURONS; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PLATELET AGGREGATION; RAW 264.7 CELLS; STROKE; THIAZOLES; TIME FACTORS;

EID: 85011838826     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-020-62766-6     Document Type: Erratum

References (48)

1. Donnan, G. A., Fisher, M., Macleod, M. & Davis, S. M. Stroke. Lancet 371, 1612-1623 (2008).
2. Qiao, H. et al. Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Res 1448, 71-81 (2012).
3. Xiong, X. Y., Liu, L. & Yang, Q. W. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Prog Neurobiol 142, 23-44 (2016).
4. Semenza, G. L. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408 (2012).
5. Laveti, D. et al. Anti-inflammatory treatments for chronic diseases: A review. Inflamm Allergy Drug Targets 12, 349-361 (2013).
6. Murakami, A. & Ohigashi, H. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121, 2357-2363 (2007).
7. Kaminska, B. MAPK signaling pathways as molecular targets for anti-inflammatory therapy from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754, 253-262 (2005).
8. Wong, C. H. & Crack, P. J. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia reperfusion injury. Curr Med Chem 15, 1-14 (2008).
9. Costello, M. J. et al. A census of marine biodiversity knowledge, resources, and future challenges. PLoS One 5, e12110 (2010).
10. Lopes, R. D. Antiplatelet agents in cardiovascular disease. J Thromb Thrombol 31, 306-309 (2011).
11. Nutescu, E. A., Shapiro, N. L., Chevalier, A. & Amin, A. N. A pharmacological overview of current and emerging anticoagulants. Clev Clin J Med 72, 2-6 (2005).
12. Motoyoshi, F. et al. The effect of photosensitive dye platonin on juvenile rheumatoid arthritis. Biotherapy 3, 241 (1991).
13. Hsiao, G. et al. Platonin, a photosensitizing dye, improves circulatory failure and mortality in rat models of endotoxemia. Biol Pharm Bull 25, 995-999 (2002).
14. Lee, J. J., Huang, W. T., Shao, D. Z., Liao, J. F. & Lin, M. T. Platonin, a cyanine photosensitizing dye, inhibits pyrogen release and results in antipyresis. J Pharmacol Sci 93, 376-380 (2003).
15. Chen, C. C. et al. Platonin attenuates LPS-induced CAT-2 and CAT-2B induction in stimulated murine macrophages. Acta Anaesthesiol Scand 50, 604-612 (2006).
16. Yeh, C. T., Kao, M. C., Chen, C. H. & Huang, C. J. Platonin preserves blood-brain barrier integrity in septic rats. Acta Anaesthesiol Taiwan 53, 12-15 (2015).
17. Huet, O. et al. Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med 35, 821-826 (2007).
18. Lo, Y. Y., Wong, J. M. & Cruz, T. F. Reactive oxygen species mediate cytokine activation of c-Jun NH2-Terminal kinases. J Biol Chem 271, 15703-15707 (1996)
19. Crack, P. J. & Taylor, J. M. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38, 1433-1444 (2005).
20. Demougeot, C. et al. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2, 2-dipyridyl in the rat photothrombotic ischemic stroke model. J Pharmacol Exp Ther 311, 1080-1087 (2004).
21. Gursoy-Ozdemir, Y., Bolay, H., Saribas, O. & Dalkara, T. Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 31, 1974-1980 (2000).
22. Tominaga, T. & Ohnishi, S. T. Interrelationship of brain edema, motor deficits, and memory impairment in rats exposed to focal ischemia. Stroke 20, 513-518 (1989).
23. Baigent, C. et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-Analysis of individual participant data from randomized trials. Lancet 373, 1849-1860 (2009).
24. Furie, K. L. et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 227-276 (2011).
25. Johnson, S. Known knowns and known unknowns: Risks associated with combination antithrombotic therapy. Thromb Res 123, S7-S11 (2008).
26. Antithrombotic Trialists Collaboration. Collaborative meta-Analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 324, 71-86 (2002).
27. Helft, G., Gilard, M., Feuvre, Le. C & Zaman, A. G. Drug insight: Antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nat Clin Pract Cardiovasc Med 3, 673-680 (2006).
28. Colman, R. W., Clowes, A. W. & George J. N. Overview of hemostasis. In: Colman, R. W. et al. (Eds.), Hemostasis and Thrombosis, 5th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 3-16 (2006).
29. Lin, K. H. et al. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo. Biochem Pharmacol 85, 1478-1485 (2013).
30. Brambilla, R., Couch, Y. & Lambertsen, K. L. The effect of stroke on immune function. Mol Cell Neurosci 53, 26-33 (2013).
31. Lambertsen, K. L., Biber, K. & Finsen, B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 32, 1677-1698 (2012).
32. Lee, S. H. et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267, 25934-25938 (1992).
33. Yenari, M. A., Xu, L., Tang, X. N., Qiao, Y. & Giffard, R. G. Microglia potentiates damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37, 1087-1093 (2006).
34. Hayashi, T. et al. c-Jun N-Terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci Lett 284, 195-199 (2000).
35. Wallace, B. K., Jelks, K. A. & ODonnell, M. E. Ischemia-induced stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransport involves p38 and JNK MAP kinases. Am J Physiol Cell Physiol 302, 505-517 (2012).
36. Chang, Y. et al. Platonin inhibited PDGF-BB-induced proliferation of rat vascular smooth muscle cells via JNK1/2-dependent signaling. Acta Pharmacol Sin 32, 1337-1344 (2011).
37. Uto, T., Fujii, M. & Hou, D. X. 6-(Methylsulfinyl) hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-Activated murine macrophages. Biochem Pharmacol 70, 1211-1221 (2005).
38. Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E. & Offen, D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54, 271-284 (2002).
39. Oliver, C. N. et al. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion induced injury to gerbil brain. Proc Natl Acad Sci USA 87, 5144-5147 (1990).
40. Santabárbara-Ruiz, P. et al. ROS-Induced JNK and p38 Signaling Is Required for Unpaired Cytokine Activation during Drosophila Regeneration. PLoS Genet 11, e1005595 (2015).
41. Ilmarinen, P., Moilanen, E. & Kankaanranta, H. Mitochondria in the center of human eosinophil apoptosis and survival. Int J Mol Sci 15, 3952-3969 (2014).
42. Lei, S. et al. Effects of N-Acetylcysteine on nicotinamide dinucleotide phosphate oxidase activation and antioxidant status in heart, lung, liver and kidney in streptozotocin-induced diabetic rats. Yonsei Med J 53, 294-303 (2012).
43. Fiordaliso, F. et al. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37, 959-968 (2004).
44. Yen, T. L. et al. Andrographolide stimulates p38 mitogen-Activated protein kinase-nuclear factor erythroid-2-related factor 2-heme oxygenase 1 signaling in primary cerebral endothelial cells for definite protection against ischemic stroke in rats. Transl Res 170, 57-72 (2016).
45. Chen, J. et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011 (2001).
46. Lu, W. J. et al. Prevention of arterial thrombosis by nobiletin: in vitro and in vivo studies. J Nutr Biochem 28, 1-8 (2016).
47. Chou, D. S. et al. ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets. Free Radic Biol Med 39, 237-248 (2005).
48. Sun, J., Zhang, X., Broderick, M. & Fein, H. Measurement of nitric oxide production in biological systems by using Griess reaction assay. Sensors 3, 276-284 (2003).